These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28189040)

  • 1. An anti-αVβ3 antibody inhibits coronary artery atherosclerosis in diabetic pigs.
    Maile LA; Busby WH; Xi G; Gollahan KP; Flowers W; Gafbacik N; Gafbacik S; Stewart K; Merricks EP; Nichols TC; Bellinger DA; Clemmons DR
    Atherosclerosis; 2017 Mar; 258():40-50. PubMed ID: 28189040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody against alphaVbeta3 integrin inhibits development of atherosclerotic lesions in diabetic pigs.
    Maile LA; Busby WH; Nichols TC; Bellinger DA; Merricks EP; Rowland M; Veluvolu U; Clemmons DR
    Sci Transl Med; 2010 Feb; 2(18):18ra11. PubMed ID: 20371482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs.
    Maile LA; Busby WH; Gollahon KA; Flowers W; Garbacik N; Garbacik S; Stewart K; Nichols T; Bellinger D; Patel A; Dunbar P; Medlin M; Clemmons D
    Endocrinology; 2014 Dec; 155(12):4665-75. PubMed ID: 25171599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.
    Shimoyama T; Hiraoka S; Takemoto M; Koshizaka M; Tokuyama H; Tokuyama T; Watanabe A; Fujimoto M; Kawamura H; Sato S; Tsurutani Y; Saito Y; Perbal B; Koseki H; Yokote K
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):675-82. PubMed ID: 20139355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.
    Maile LA; Gollahon K; Wai C; Dunbar P; Busby W; Clemmons D
    J Diabetes Res; 2014; 2014():421827. PubMed ID: 25389530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway.
    He Y; Zou P; Lu Y; Jia D; Li X; Yang H; Tang L; Zhu Z; Tu T; Tai S; Xiao Y; Chen M; Lu L; Zhou S
    J Mol Cell Cardiol; 2020 Feb; 139():1-13. PubMed ID: 31958462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells.
    Pathak A; Zhao R; Huang J; Stouffer GA
    Cardiovasc Diabetol; 2008 Dec; 7():36. PubMed ID: 19108709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by beta3 integrin signaling.
    Panchatcharam M; Miriyala S; Yang F; Leitges M; Chrzanowska-Wodnicka M; Quilliam LA; Anaya P; Morris AJ; Smyth SS
    Int J Biochem Cell Biol; 2010 Jun; 42(6):965-74. PubMed ID: 20184965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty.
    Theilmeier G; Quarck R; Verhamme P; Bochaton-Piallat ML; Lox M; Bernar H; Janssens S; Kockx M; Gabbiani G; Collen D; Holvoet P
    Cardiovasc Res; 2002 Aug; 55(2):385-95. PubMed ID: 12123778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo.
    Candido R; Toffoli B; Corallini F; Bernardi S; Zella D; Voltan R; Grill V; Celeghini C; Fabris B
    J Vasc Res; 2010; 47(3):252-61. PubMed ID: 19907187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical stretch inhibits oxidized low density lipoprotein-induced apoptosis in vascular smooth muscle cells by up-regulating integrin alphavbeta3 and stablization of PINCH-1.
    Cheng J; Zhang J; Merched A; Zhang L; Zhang P; Truong L; Boriek AM; Du J
    J Biol Chem; 2007 Nov; 282(47):34268-75. PubMed ID: 17878168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
    Wamhoff BR; Dixon JL; Sturek M
    J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3.
    Maile LA; Busby WH; Sitko K; Capps BE; Sergent T; Badley-Clarke J; Clemmons DR
    Mol Endocrinol; 2006 Feb; 20(2):405-13. PubMed ID: 16195248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
    Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
    Shen X; Li H; Li W; Wu X; Ding X
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular smooth muscle cells premature senescence with rutin attenuates and stabilizes diabetic atherosclerosis.
    Li Y; Qin R; Yan H; Wang F; Huang S; Zhang Y; Zhong M; Zhang W; Wang Z
    J Nutr Biochem; 2018 Jan; 51():91-98. PubMed ID: 29107826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
    Ashino T; Yamamoto M; Yoshida T; Numazawa S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
    Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.